Table 1.
The baseline information of included studies.
| Author | Year | Country | No. of patients | Nos. score | Definition of ERAS failure | Surgery type | Diagnosis | Follow up |
|---|---|---|---|---|---|---|---|---|
| Hughes | 2016 | UK | 603 | 7 | severe morbidity (Clavien Dindo grade≥3) | laparoscopic and open | HCC (n = 75) CLM (n = 381) other malignancy (n = 84) benign (n = 63) |
30 days |
| Lee | 2014 | China | 194 | 6 | length of ICU stay more than 24 h after surgery unplanned admission to ICU within 3 0 days after surgery readmission to the hospital within 3 0 days after surgery reoperation for complications 30-day mortality |
laparoscopic and open | NA | 30 days |
| Takamoto | 2014 | Japan | 200 | 6 | On postoperative day 6, if following criteria were not met: normal or decreasing serum bilirubin level absence of fever (<37.5C for >48 h) adequate pain control with oral analgesics only ability to consume water and solid foods without requiring intravenous fluids adequate mobilization independently or at the preoperative level | open | HCC (n = 55) metastases (n = 85) other malignancy (n = 60) benign (n = 14) |
6 days |
| Wong-Lun-Hing | 2017 | Netherland | 53 | 7 | severe morbidity (Clavien Dindo grade≥3a) | laparoscopic and open | HCC (n = 24) metastases (n = 421) other malignancy (n = 41) benign (n = 47) other (n = 5) |
90 days |